Ardent Health Partners, LLC (NYSE:ARDT - Get Free Report) has been assigned a consensus recommendation of "Buy" from the twelve ratings firms that are currently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $22.00.
A number of research firms have recently commented on ARDT. Royal Bank of Canada restated an "outperform" rating and set a $23.00 price objective on shares of Ardent Health Partners in a research note on Thursday, November 14th. Stephens reissued an "overweight" rating and set a $24.00 price target on shares of Ardent Health Partners in a research report on Thursday, September 19th. KeyCorp started coverage on Ardent Health Partners in a research report on Friday, October 11th. They set an "overweight" rating and a $24.00 price target on the stock. Truist Financial decreased their target price on shares of Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating for the company in a research note on Monday. Finally, JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $20.00 price target on shares of Ardent Health Partners in a research report on Tuesday, December 17th.
View Our Latest Stock Report on ARDT
Ardent Health Partners Price Performance
Shares of NYSE ARDT traded up $0.05 during midday trading on Thursday, reaching $16.41. The company's stock had a trading volume of 97,685 shares, compared to its average volume of 235,177. The stock has a 50 day simple moving average of $16.62. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. Ardent Health Partners has a fifty-two week low of $14.57 and a fifty-two week high of $20.72.
Institutional Trading of Ardent Health Partners
Large investors have recently modified their holdings of the stock. State Street Corp bought a new stake in Ardent Health Partners during the third quarter worth $1,977,000. Jane Street Group LLC acquired a new position in shares of Ardent Health Partners during the 3rd quarter worth $567,000. Allspring Global Investments Holdings LLC bought a new stake in shares of Ardent Health Partners during the 3rd quarter worth $13,119,000. Goldentree Asset Management LP acquired a new stake in Ardent Health Partners in the third quarter valued at about $22,897,000. Finally, Franklin Resources Inc. bought a new position in Ardent Health Partners in the third quarter valued at about $15,839,000.
About Ardent Health Partners
(
Get Free ReportArdent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Further Reading
Before you consider Ardent Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.
While Ardent Health Partners currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
